Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1994 May 1;476(3):517–529. doi: 10.1113/jphysiol.1994.sp020151

Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.

L Tian 1, C Prior 1, J Dempster 1, I G Marshall 1
PMCID: PMC1160464  PMID: 7914535

Abstract

1. The frequency (0.5-150 Hz) and calcium dependence (0.5-2.0 mM) of the effects of the nicotinic antagonist tubocurarine (0.2 microM) on acetylcholine (ACh) liberation from motor nerve terminals has been examined using binomial analysis of quantal transmitter release. 2. At an extracellular calcium ion concentration ([Ca2+]o) of 2.0 mM, tubocurarine produced a decrease in the endplate current (EPC) quantal content of approximately 30% at high frequencies of motor nerve stimulation (50-150 Hz). In contrast, at low frequencies of stimulation (0.5-1.0 Hz), tubocurarine enhanced the EPC quantal content by approximately 20%. 3. The enhancement of EPC quantal content produced by tubocurarine at low frequencies of motor nerve stimulation was [Ca2+]o dependent, being abolished when [Ca2+]o was lowered from 2.0 to 0.5 mM. In contrast, the decrease in quantal content produced by tubocurarine at high frequencies of motor nerve stimulation was independent of [Ca2+]o, being approximately 30% at all calcium ion concentrations studied. 4. In direct contrast to tubocurarine, the nicotinic antagonist vecuronium (1.0 microM) produced no increase in EPC quantal content at low frequencies of nerve stimulation. However, at high frequencies of nerve stimulation it decreased EPC quantal content to a similar extent to 0.2 microM tubocurarine. The frequency-dependent decrease in EPC quantal content produced by 1.0 microM vecuronium in 2.0 mM [Ca2+]o was very similar to that seen with 0.2 microM tubocurarine in 0.5 mM [Ca2+]o. 5. Binomial analysis revealed that all the changes in EPC quantal content associated with both nicotinic antagonists were due to changes in the size of the pool of quanta in the nerve terminal available for immediate release with no effect on the probability of release of an individual quantum. 6. The results are interpreted in terms of two separately identifiable prejunctional actions of the nicotinic antagonists, both involving an action at nicotinic ACh receptors situated on the motor nerve terminal. Thus, at high frequencies of motor nerve stimulation tubocurarine and vecuronium produce a [Ca2+]o-independent decrease in ACh release, probably through an inhibitory action on a positive-feedback prejunctional nicotinic autoreceptor closely related to the muscle-type nicotinic ACh autoreceptor. However, at low frequencies of motor nerve stimulation we suggest that tubocurarine, but not vecuronium, produces a [Ca2+]o-dependent increase in ACh release through an action at a negative-feedback prejunctional neuronal-type nicotinic ACh autoreceptor.

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augustine G. J., Charlton M. P., Smith S. J. Calcium action in synaptic transmitter release. Annu Rev Neurosci. 1987;10:633–693. doi: 10.1146/annurev.ne.10.030187.003221. [DOI] [PubMed] [Google Scholar]
  2. Barstad J. A., Lilleheil G. Transversaly cut diaphragm preparation from rat. An adjuvant tool in the study of the physiology and pbarmacology of the myoneural junction. Arch Int Pharmacodyn Ther. 1968 Oct;175(2):373–390. [PubMed] [Google Scholar]
  3. Birmingham A. T., Hussain S. Z. A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants. Br J Pharmacol. 1980 Nov;70(3):501–506. doi: 10.1111/j.1476-5381.1980.tb08730.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blaber L. C. The prejunctional actions of some non-depolarizing blocking drugs. Br J Pharmacol. 1973 Jan;47(1):109–116. doi: 10.1111/j.1476-5381.1973.tb08163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blaer L. C. The effect of facilitatory concentrations of decamethonium on the storage and release of transmitter at the neuromuscular junction of the cat. J Pharmacol Exp Ther. 1970 Dec;175(3):664–672. [PubMed] [Google Scholar]
  6. Bowman W. C., Marshall I. G., Gibb A. J., Harborne A. J. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci. 1988 Jan;9(1):16–20. doi: 10.1016/0165-6147(88)90236-2. [DOI] [PubMed] [Google Scholar]
  7. Bowman W. C., Prior C., Marshall I. G. Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci. 1990;604:69–81. doi: 10.1111/j.1749-6632.1990.tb31983.x. [DOI] [PubMed] [Google Scholar]
  8. Bowman W. C., Webb S. N. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat. J Pharm Pharmacol. 1972 Oct;24(10):762–772. doi: 10.1111/j.2042-7158.1972.tb08880.x. [DOI] [PubMed] [Google Scholar]
  9. DEL CASTILLO J., KATZ B. Quantal components of the end-plate potential. J Physiol. 1954 Jun 28;124(3):560–573. doi: 10.1113/jphysiol.1954.sp005129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Deneris E. S., Connolly J., Rogers S. W., Duvoisin R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci. 1991 Jan;12(1):34–40. doi: 10.1016/0165-6147(91)90486-c. [DOI] [PubMed] [Google Scholar]
  11. Dionne V. E., Stevens C. F. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox. J Physiol. 1975 Oct;251(2):245–270. doi: 10.1113/jphysiol.1975.sp011090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Durant N. N., Bowman W. C., Marshall I. G. A comparison of the neuromuscular and autonomic blocking activities of (+)-tubocurarine and its N-methyl and O,O,N-trimethyl analogues. Eur J Pharmacol. 1977 Dec 15;46(4):297–302. doi: 10.1016/0014-2999(77)90223-0. [DOI] [PubMed] [Google Scholar]
  13. Durant N. N., Marshall I. G., Savage D. S., Nelson D. J., Sleigh T., Carlyle I. C. The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45, and other pancuronium analogues, in the cat. J Pharm Pharmacol. 1979 Dec;31(12):831–836. doi: 10.1111/j.2042-7158.1979.tb13675.x. [DOI] [PubMed] [Google Scholar]
  14. Ferry C. B., Kelly S. S. The nature of the presynaptic effects of (+)-tubocurarine at the mouse neuromuscular junction. J Physiol. 1988 Sep;403:425–437. doi: 10.1113/jphysiol.1988.sp017257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gallagher J. P., Blaber L. C. Catechol, a facilitatory drug that demonstrates only a prejunctional site of action. J Pharmacol Exp Ther. 1973 Jan;184(1):129–135. [PubMed] [Google Scholar]
  16. Gibb A. J., Marshall I. G. Pre-and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat. J Physiol. 1984 Jun;351:275–297. doi: 10.1113/jphysiol.1984.sp015245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Glavinović M. I. Change of statistical parameters of transmitter release during various kinetic tests in unparalysed voltage-clamped rat diaphragm. J Physiol. 1979 May;290(2):481–497. doi: 10.1113/jphysiol.1979.sp012785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Glavinović M. I. Presynaptic action of curare. J Physiol. 1979 May;290(2):499–506. doi: 10.1113/jphysiol.1979.sp012786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Glavinović M. I. Voltage clamping of unparalysed cut rat diaphragm for study of transmitter release. J Physiol. 1979 May;290(2):467–480. doi: 10.1113/jphysiol.1979.sp012784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. HUTTER O. F. Post-tetanic restoration of neuromuscular transmission blocked by D-tubocurarine. J Physiol. 1952 Oct;118(2):216–227. doi: 10.1113/jphysiol.1952.sp004788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hubbard J. I., Wilson D. F. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine. J Physiol. 1973 Jan;228(2):307–325. doi: 10.1113/jphysiol.1973.sp010088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Katz B., Miledi R. Transmitter leakage from motor nerve endings. Proc R Soc Lond B Biol Sci. 1977 Feb 11;196(1122):59–72. doi: 10.1098/rspb.1977.0029. [DOI] [PubMed] [Google Scholar]
  23. LILEY A. W., NORTH K. A. An electrical investigation of effects of repetitive stimulation on mammalian neuromuscular junction. J Neurophysiol. 1953 Sep;16(5):509–527. doi: 10.1152/jn.1953.16.5.509. [DOI] [PubMed] [Google Scholar]
  24. LILEY A. W. The quantal components of the mammalian end-plate potential. J Physiol. 1956 Sep 27;133(3):571–587. doi: 10.1113/jphysiol.1956.sp005610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Magleby K. L., Pallotta B. S., Terrar D. A. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog. J Physiol. 1981 Mar;312:97–113. doi: 10.1113/jphysiol.1981.sp013618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Matzner H., Parnas H., Parnas I. Presynaptic effects of d-tubocurarine on neurotransmitter release at the neuromuscular junction of the frog. J Physiol. 1988 Apr;398:109–121. doi: 10.1113/jphysiol.1988.sp017032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miyamoto M. D. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions. J Physiol. 1975 Aug;250(1):121–142. doi: 10.1113/jphysiol.1975.sp011045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Molgo J., Lemeignan M., Lechat P. Effects of 4-aminopyridine at the frog neuromuscular junction. J Pharmacol Exp Ther. 1977 Dec;203(3):653–663. [PubMed] [Google Scholar]
  29. Mulle C., Choquet D., Korn H., Changeux J. P. Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation. Neuron. 1992 Jan;8(1):135–143. doi: 10.1016/0896-6273(92)90115-t. [DOI] [PubMed] [Google Scholar]
  30. Mulle C., Léna C., Changeux J. P. Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron. 1992 May;8(5):937–945. doi: 10.1016/0896-6273(92)90208-u. [DOI] [PubMed] [Google Scholar]
  31. OTSUKA M., NONOMURA Y. The action of phenolic substances on motor nerve endings. J Pharmacol Exp Ther. 1963 Apr;140:41–45. [PubMed] [Google Scholar]
  32. PATON W. D. M., ZAIMIS E. The methonium. Pharmacol Rev. 1952 Sep;4(3):219–253. [PubMed] [Google Scholar]
  33. Prior C., Dempster J., Marshall I. G. Electrophysiological analysis of transmission at the skeletal neuromuscular junction. J Pharmacol Toxicol Methods. 1993 Sep;30(1):1–17. doi: 10.1016/1056-8719(93)90002-v. [DOI] [PubMed] [Google Scholar]
  34. Sands S. B., Barish M. E. Calcium permeability of neuronal nicotinic acetylcholine receptor channels in PC12 cells. Brain Res. 1991 Sep 27;560(1-2):38–42. doi: 10.1016/0006-8993(91)91211-i. [DOI] [PubMed] [Google Scholar]
  35. Searl T., Prior C., Marshall I. G. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium. J Physiol. 1991 Dec;444:99–116. doi: 10.1113/jphysiol.1991.sp018868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vernino S., Amador M., Luetje C. W., Patrick J., Dani J. A. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron. 1992 Jan;8(1):127–134. doi: 10.1016/0896-6273(92)90114-s. [DOI] [PubMed] [Google Scholar]
  37. Wessler I., Halank M., Rasbach J., Kilbinger H. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):365–372. doi: 10.1007/BF00569371. [DOI] [PubMed] [Google Scholar]
  38. Wilson D. F. Effects of caffeine on neuromuscular transmission in the rat. Am J Physiol. 1973 Oct;225(4):862–865. doi: 10.1152/ajplegacy.1973.225.4.862. [DOI] [PubMed] [Google Scholar]
  39. Wilson D. F. Influence of presynaptic receptors on neuromuscular transmission in rat. Am J Physiol. 1982 May;242(5):C366–C372. doi: 10.1152/ajpcell.1982.242.5.C366. [DOI] [PubMed] [Google Scholar]
  40. Wilson D. F., Thomsen R. H. Effects of hexamethonium on transmitter release from the rat phrenic nerve. Neurosci Lett. 1992 Aug 31;143(1-2):79–82. doi: 10.1016/0304-3940(92)90237-2. [DOI] [PubMed] [Google Scholar]
  41. Wilson D. F., Thomsen R. H. Nicotinic receptors on the rat phrenic nerve: evidence for negative feedback. Neurosci Lett. 1991 Nov 11;132(2):163–166. doi: 10.1016/0304-3940(91)90292-2. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES